156 related articles for article (PubMed ID: 36222869)
21. Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinoma.
Wang M; Xi Y; Wang L; Chen H; Jiang F; Ding Z
Radiat Oncol; 2024 Feb; 19(1):26. PubMed ID: 38418994
[TBL] [Abstract][Full Text] [Related]
22. Machine learning-based radiomics for predicting outcomes in cervical cancer patients undergoing concurrent chemoradiotherapy.
Xin W; Rixin S; Linrui L; Zhihui Q; Long L; Yu Z
Comput Biol Med; 2024 Jul; 177():108593. PubMed ID: 38801795
[TBL] [Abstract][Full Text] [Related]
23. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
[TBL] [Abstract][Full Text] [Related]
24. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
[TBL] [Abstract][Full Text] [Related]
25. Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy.
Perucho JAU; Wang M; Tse KY; Ip PPC; Siu SWK; Ngan HYS; Khong PL; Lee EYP
Eur Radiol; 2021 Mar; 31(3):1727-1735. PubMed ID: 32885298
[TBL] [Abstract][Full Text] [Related]
26. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
[TBL] [Abstract][Full Text] [Related]
27. CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment.
Chen NB; Xiong M; Zhou R; Zhou Y; Qiu B; Luo YF; Zhou S; Chu C; Li QW; Wang B; Jiang HH; Guo JY; Peng KQ; Xie CM; Liu H
Radiat Oncol; 2022 Nov; 17(1):184. PubMed ID: 36384755
[TBL] [Abstract][Full Text] [Related]
28. Preoperative Prediction of Lymph Node Metastasis of Pancreatic Ductal Adenocarcinoma Based on a Radiomics Nomogram of Dual-Parametric MRI Imaging.
Shi L; Wang L; Wu C; Wei Y; Zhang Y; Chen J
Front Oncol; 2022; 12():927077. PubMed ID: 35875061
[TBL] [Abstract][Full Text] [Related]
29. Radiomics Based on T2-Weighted Imaging and Apparent Diffusion Coefficient Images for Preoperative Evaluation of Lymph Node Metastasis in Rectal Cancer Patients.
Li C; Yin J
Front Oncol; 2021; 11():671354. PubMed ID: 34041033
[TBL] [Abstract][Full Text] [Related]
30. Comparing deep learning and handcrafted radiomics to predict chemoradiotherapy response for locally advanced cervical cancer using pretreatment MRI.
Jeong S; Yu H; Park SH; Woo D; Lee SJ; Chong GO; Han HS; Kim JC
Sci Rep; 2024 Jan; 14(1):1180. PubMed ID: 38216687
[TBL] [Abstract][Full Text] [Related]
31. Radiomics signature as a new biomarker for preoperative prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
Zhang Z; Jiang X; Zhang R; Yu T; Liu S; Luo Y
Diagn Interv Radiol; 2021 May; 27(3):308-314. PubMed ID: 34003118
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a radiomics signature on differentially expressed features of
Cao Q; Li Y; Li Z; An D; Li B; Lin Q
Radiother Oncol; 2020 May; 146():9-15. PubMed ID: 32065875
[TBL] [Abstract][Full Text] [Related]
33. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
[TBL] [Abstract][Full Text] [Related]
34. Patient survival prediction in locally advanced cervical squamous cell carcinoma using MRI-based radiomics: retrospective cohort study.
Bseiso A; Saqib M; Saigol MS; Rehman A; Sare A; Yagoub AE; Mumtaz H
Ann Med Surg (Lond); 2023 Nov; 85(11):5328-5336. PubMed ID: 37915655
[TBL] [Abstract][Full Text] [Related]
35. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
Zheng X; Guo W; Dong J; Qian L
Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
[TBL] [Abstract][Full Text] [Related]
36. MRI-derived radiomics analysis improves the noninvasive pretreatment identification of multimodality therapy candidates with early-stage cervical cancer.
Li Y; Ren J; Yang JJ; Cao Y; Xia C; Lee EYP; Chen B; Guan H; Qi YF; Gao X; Tang W; Chen K; Jin ZY; He YL; Xiang Y; Xue HD
Eur Radiol; 2022 Jun; 32(6):3985-3995. PubMed ID: 35018480
[TBL] [Abstract][Full Text] [Related]
37. [Application of MRI-based Radiomics Models in the Assessment of Hepatic Metastasis of Rectal Cancer].
Hu SX; Yang K; Wang XR; Wen DG; Xia CC; Li X; Li ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):311-318. PubMed ID: 33829708
[TBL] [Abstract][Full Text] [Related]
38. Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.
Ma M; Gan L; Liu Y; Jiang Y; Xin L; Liu Y; Qin N; Cheng Y; Liu Q; Xu L; Zhang Y; Wang X; Zhang X; Ye J; Wang X
Eur J Radiol; 2022 Jan; 146():110095. PubMed ID: 34890936
[TBL] [Abstract][Full Text] [Related]
39. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
[TBL] [Abstract][Full Text] [Related]
40. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
